Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Consensus Recommendations – Advanced Breast Cancer (ABC 4)

4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)

Published in 2018 – Ann Oncol (2018); 29: 1634–1657
Authors: F. Cardoso, E. Senkus, A. Costa, E. Papadopoulos, M. Aapro, F. André, N. Harbeck, B. Aguilar Lopez, C. H. Barrios, J. Bergh, L. Biganzoli, C. B. Boers-Doets, M. J. Cardoso, L. A. Carey, J. Cortés, G. Curigliano, V. Diéras, N. S. El Saghir, A. Eniu, L. Fallowfield, P. A. Francis, K. Gelmon, S. R. D. Johnston, B. Kaufman, S. Koppikar, I. E. Krop, M. Mayer, G. Nakigudde, B. V. Offersen, S. Ohno, O. Pagani, S. Paluch-Shimon, F. Penault-Llorca, A. Prat, H. S. Rugo, G. W. Sledge, D. Spence, C. Thomssen, D. A. Vorobiof, B. Xu, L. Norton & E. P. Winer

The ESO-ESMO 4th international consensus guidelines for advanced breast cancer (ABC 4) focus on methodology, assessment guidelines and treatment recommendations for specific breast cancer subtypes including ER positive/HER2-negative (luminal) ABC, HER2-positive ABC, triple-negative ABC and male metastatic breast cancer, as well as patients with specific metastases. Supportive and palliative care recommendations are also included and a new section addresses integrative medicine.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings